聞泰科技(600745.SH):雲南省城投解押599萬股
格隆匯7月31日丨聞泰科技(600745.SH)公佈,公司於2020年7月31日收到公司股東雲南省城投通知,獲悉其將所持有的公司599萬股股份辦理了解除質押。
雲南省城投持有公司股份9112.64萬股(其中無限售流通股5000萬股,限售股4112.64萬股),佔公司總股本的7.32%,雲南融智投資有限公司(以下簡稱“雲南融智”)持有公司無限售流通股2821.33萬股,佔公司總股本的2.27%;雲南省城投與雲南融智為一致行動人。本次解除部分股權質押後,雲南省城投與雲南融智合計累計質押公司股份1.13億股,佔雙方合計持有公司股份總數的94.34%,佔公司總股本的9.04%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.